Diagnosis and treatment strategies in patients with NSCLC with or without EGFR mutations. - IDENTIFY

Study identifier:NIS-OAR-XXX-2011/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Study of cases and controls on diagnosis and treatment strategies in patients with NSCLC with or without EGFR mutations.

Medical condition

Stage IIIB/IV

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

450

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 May 2012
Primary Completion Date: 01 Nov 2013
Study Completion Date: 01 Nov 2013

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2014 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria